(10) Gut Health and Healing Research in model organismss indicates that BPC-157 may support gut health by: Strengthening the Gut Lining: Enhances the mucosal integrity, which is the protective layer of the stomach and intestines Reducing Inflammation: Helps calm gut irritation and inflammatory conditions Promoting Tissue Repair: Accelerates the healing of damaged tissue in the gut Protecting Blood Vessels: Supports healthy blood vessel function, improving circulation to injured areas These effects have been observed in several conditions: Gastric Ulcers: Accelerates healing, outperforms some ulcer medications, and promotes tissue regeneration (11) Inflammatory Bowel Disease (IBD): Enhances mucosal integrity, reduces inflammation, and supports epithelial repair (12) Gut Surgery: Improves healing of intestinal connections (anastomoses) and abnormal gut fistulas (13, 14) Overall Gut Health: Supports blood vessel formation, protects the gut lining, and may help with IBS symptoms (12) Damage Protection: Shields against alcohol, Nonsteroidal anti-inflammatory drugs (NSAIDs) are over-the-counter medications commonly used to reduce inflammation and pain NSAIDs, and toxins while aiding healing in the esophagus, liver, and pancreas (13) Neurological Protection and the Gut-Brain Axis Animal studies have demonstrated that BPC-157 has broad neuroprotective and therapeutic effects, including: Neuroprotection and Recovery: Supports nerve regeneration, protects against spinal cord injury, brain trauma, and neurotoxicity (14, 15) Neurotransmitter Regulation: Modulates dopamine, serotonin, and GABA, influencing seizures, tremors, addiction, and neurological disorders (16) Behavioral and Cognitive Support: Improves motor function, learning, mood disorders, and neurological decline (16) By promoting both gut healing and neuroprotection, BPC-157 is a promising therapy for conditions linked to the gut-brain axis, supporting systemic healing and recovery
A 0.5% topical solution worked better than lower concentrations
Diabetologia 48, 24702476
Im 67 and I work as a flight attendant
Oligo sequences for competition library: Human SLC25A40 sg1 F: caccGGTTGGATTTCCCTTTGGAG, sg1 R: aaacCTCCAAAGGGAAATCCAACC, sg5 F: caccgAAGAGGGAGGCAACAAACTA, sg5 R: aaacTAGTTTGTTGCCTCCCTCTTc, sg6 F: caccgAAGAAGCCAGGAAATTTCCA, sg6 R: aaacTGGAAATTTCCTGGCTTCTTc, sg7 F: caccGGTACATCTCTAAGAACAGT, sg7 R: aaacACTGTTCTTAGAGATGTACC, sg8 F: caccgCTATGTGTCTGTGAAGAGGG, sg8 R: aaacCCCTCTTCACAGACACATAGc, Human TXNRD2 sg2 F: caccgTAAACCACTGGAGTTCACGG, sg2 R: aaacCCGTGAACTCCAGTGGTTTAc, sg3 F: caccGATTAGGAGGGCGCTTCCGG, sg3 R: aaacCCGGAAGCGCCCTCCTAATC, sg6 F: caccgCAAGAAGCTGATGCACCAGG, sg6 R: aaacCCTGGTGCATCAGCTTCTTGc, sg7 F: caccGCACTACCTGGTCGAAGCCG, sg7 R: aaacCGGCTTCGACCAGGTAGTGC, sg8 F: caccGGAGGACAGCACCACCGGCA, sg8 R: aaacTGCCGGTGGTGCTGTCCTCC, Control sg5 F: GCGGATTAGAGGTAATGCGG, sg5 R: CCGCATTACCTCTAATCCGC, sg6 F: GGAGCCATGGTAGAGCGTAT, sg6 R: ATACGCTCTACCATGGCTCC, sg11 F: GGCGCTCGATTAAGACTCAG, sg11 R: CTGAGTCTTAATCGAGCGCC, sg12 F: GTTACGCGTGCTGTCGCTTC, sg12 R: GAAGCGACAGCACGCGTAAC, sg13 F: GTTCCTTCTGCAGGCACGCT, sg13 R: AGCGTGCCTGCAGAAGGAAC Analysis of transcriptome-wide association studies (TWAS) data We analyzed transcriptome-wide association studies (TWAS) results on 4,000 traits for SLC25A39 in the UK Biobank 12 (n=361,194) using the summary-statistics-based, joint-tissue PrediXcan 51,52
